Griffin Asset Management Inc. decreased its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 2.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 34,824 shares of the company’s stock after selling 923 shares during the period. Griffin Asset Management Inc.’s holdings in Procter & Gamble were worth $5,548,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of PG. Kingstone Capital Partners Texas LLC raised its position in Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares during the last quarter. Nuveen LLC bought a new position in Procter & Gamble during the 1st quarter valued at approximately $1,954,941,000. Price T Rowe Associates Inc. MD raised its position in Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Invesco Ltd. raised its position in Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after purchasing an additional 2,228,151 shares during the last quarter. Finally, Valeo Financial Advisors LLC raised its position in Procter & Gamble by 1,875.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after purchasing an additional 1,674,139 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Down 0.6%
Shares of NYSE:PG opened at $149.69 on Monday. The stock has a fifty day simple moving average of $155.24 and a two-hundred day simple moving average of $159.41. The stock has a market capitalization of $350.34 billion, a price-to-earnings ratio of 22.99, a PEG ratio of 3.97 and a beta of 0.36. Procter & Gamble Company has a 12-month low of $149.45 and a 12-month high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.
Insider Buying and Selling at Procter & Gamble
In other Procter & Gamble news, CFO Andre Schulten sold 11,638 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the sale, the chief financial officer directly owned 52,642 shares in the company, valued at approximately $8,279,007.34. This trade represents a 18.11% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the sale, the chief executive officer owned 34,978 shares in the company, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock valued at $23,421,279 in the last ninety days. Corporate insiders own 0.20% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have commented on PG. BNP Paribas Exane lowered their price target on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, September 23rd. BNP Paribas reiterated an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a report on Friday, August 15th. JPMorgan Chase & Co. reduced their target price on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a report on Friday. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a report on Wednesday, October 8th. Finally, Barclays reduced their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat, Procter & Gamble presently has an average rating of “Moderate Buy” and an average price target of $172.21.
Get Our Latest Analysis on Procter & Gamble
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More
- Five stocks we like better than Procter & Gamble
- Stock Market Upgrades: What Are They?
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- Investing in Travel Stocks Benefits
- Could Target’s Week of Discounts Come Full Circle for Investors?
- What is a SEC Filing?
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.